Castellino, A.
Chiappella, A.
LaPlant, B. R.
Pederson, L. D. http://orcid.org/0000-0001-5902-8882
Gaidano, G.
Macon, W. R.
Inghirami, G.
Reeder, C. B.
Tucci, A.
King, R. L. http://orcid.org/0000-0002-7132-0226
Congiu, A.
Foran, J. M.
Pavone, V.
Rivera, C. E.
Spina, M.
Ansell, S. M.
Cavallo, F.
Molinari, A. L.
Ciccone, Giovannino
Habermann, T. M.
Witzig, T. E.
Vitolo, U.
Nowakowski, G. S.
Funding for this research was provided by:
ACh: advisory board: Celgene, Janssen; honoraria for lectures: Amgen, Celgene, Janssen, Nanostring, Roche, Teva.
GG: consultancy: Roche, Karyopharm, Morphosys, Gilead, Janssen, Novartis; honoraria: Roche, Karyopharm, Morphosys, Gilead, Janssen, Novartis; speakers bureau: Roche, Gilead, Janssen, Novartis.
Celgene grants during the study conductions.
FC: honoraria: Celgene, Onyx, Janssen.
honoraria from Celgene, personal fees from Seattle genetics, outside the submitted work
advisory board: Roche, Celgene, Janssen; honoraria for lectures: Roche, Celgene, Takeda, Gilead, Janssen, Mundipharma; research funding: Roche, Celgene.
consultancy: Bayer; research funding: Bayer, Celgene, Morphosys, Nanostring tecnologies.
Article History
Received: 28 June 2018
Revised: 12 September 2018
Accepted: 25 September 2018
First Online: 8 November 2018
Conflict of interest
: A.Ch.: advisory board: Celgene, Janssen; honoraria for lectures: Amgen, Celgene, Janssen, Nanostring, Roche, Teva. G.G.: consultancy: Roche, Karyopharm, Morphosys, Gilead, Janssen, Novartis; honoraria: Roche, Karyopharm, Morphosys, Gilead, Janssen, Novartis; speakers bureau: Roche, Gilead, Janssen, Novartis. J.M.F.: Celgene grants during the study conductions. F.C.: honoraria: Celgene, Onyx, Janssen. T.E.W.: honoraria from Celgene, personal fees from Seattle genetics, outside the submitted work. U.V.: advisory board: Roche, Celgene, Janssen; honoraria for lectures: Roche, Celgene, Takeda, Gilead, Janssen, Mundipharma; research funding: Roche, Celgene. G.N.: consultancy: Bayer; research funding: Bayer, Celgene, Morphosys, Nanostring tecnologies. The remaining authors declare that they have no conflict of interest.